The US Food and Drug Administration (FDA) approved drug labeling changes for 6 menopausal hormone therapy products to clarify risk considerations.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 24 Mar 2026.
The item focuses on FDA Approves Menopausal Hormone Therapy Labeling Changes.
Review the original article for the full source wording and details.